Androgen receptor profiling predicts prostate cancer outcome

Androgen receptor profiling predicts prostate cancer outcome

Abstract Prostate cancer is the second most prevalent malignancy in men. Biomarkers for outcome prediction are urgently needed, so that high‐risk patients could be monitored more closely postoperatively. To identify prognostic markers and to determine causal players in prostate cancer progression, w...

Full description

Bibliographic Details
Main Authors: Suzan Stelloo, Ekaterina Nevedomskaya, Henk G van der Poel, Jeroen de Jong, Geert JLH van Leenders, Guido Jenster, Lodewyk FA Wessels, Andries M Bergman, Wilbert Zwart
Format: Article
Language:English
Published: Springer Nature 2015-09-01
Series:EMBO Molecular Medicine
Subjects:
androgen receptor profiling
ChIP‐seq
companion diagnostics for prostate cancer
FAIRE‐seq
treatment prediction
Online Access:https://doi.org/10.15252/emmm.201505424

Internet

https://doi.org/10.15252/emmm.201505424

Similar Items